Pomalidomide

Red

Brand Name(s):Celgene

Indication:Multiple myeloma

Rationale:1,2,3

Considered:Jul-13

Review Date:Feb-22

Comments:
NICE TA 427
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib
Jan-2016
…………………………
Drug Safety Update
Before starting treatment with pomalidomide, establish hepatitis B virus status in all patients
May 2016
NICE TA338
Pomalidomide (Imnovid), given with a drug called dexamethasone, is not recommended for treating relapsed and refractory multiple myeloma in people whose disease has gotten worse despite having had both lenalidomide and bortezomib.
March 2015
…………………………
MHRA Guidance Sept 2013
For information: http://www.mhra.gov.uk/home/groups/plp/documents/drugsafetymessage/con321962.pdf